倍他洛尔在中年患者中的药代动力学
Pharmacokinetics of betaxolol in middle aged patients.
作者信息
Bianchetti G, Thiercelin J F, Thenot J P
出版信息
Eur J Clin Pharmacol. 1986;31(2):231-3. doi: 10.1007/BF00606665.
PMID:2879735
Abstract
The pharmacokinetics of betaxolol was studied in 8 middle-aged (40-60 years) subjects after oral (20 mg) and intravenous (10 mg) administration. The principal parameters were almost identical to those observed in young healthy volunteers. The recommended therapeutic regimen, a single daily dose of 20 mg, appears well suited for middle aged, hypertensive patients.
摘要
在8名中年（40 - 60岁）受试者口服（20毫克）和静脉注射（10毫克）倍他洛尔后，对其药代动力学进行了研究。主要参数与在年轻健康志愿者中观察到的几乎相同。推荐的治疗方案为每日单次剂量20毫克，似乎非常适合中年高血压患者。
Zotero 插件